Billionaire Druckenmiller's Top Dividend Stock Picks
Stanley Druckenmiller was one of the fund managers for the Quantum Fund founded by George Soros.
Abbvie Inc. (ABBV)
Market is closed
News
- First
- << Previous
- 381 - 390
- Next >>
AbbVie Inc (ABBV) Awaits NDA Approval For Hepatitis C Treatment
A New Drug Application (NDA) by AbbVie Inc (NYSE:ABBV) that will be used for the treatment of Hepatitis C is at the mercy the U.S. Food and Drug Administration.
Billionaire Larry Robbins Knows How To Pick Mega-Cap Stocks
Larry Robbins’ Glenview Capital Management reported an equity portfolio worth over $13.98 billion in its latest 13F filing.
Billionaire Larry Robbins Confidently Piles Into CBS, Anthem, As Merger Battles Continue
Larry Robbins is a billionaire investor and businessman who founded the New York-based hedge fund Glenview Capital in 2000. Mr.
Is AbbVie Inc (ABBV) A Good Stock To Buy?
Hedge funds are not perfect. They have their bad picks just like everyone else. Valeant, a stock hedge funds have loved, lost 79% during the last 12 months ending in November 21.
Gilead Sciences, Inc. (GILD) Takes Lead Against AbbVie Inc (ABBV) On Crohn's Disease Treatment
Gilead Sciences, Inc. (NASDAQ:GILD) might as well have quashed rumors making waves claiming it is planning to acquire Belgium-based Galapagos NV (ADR) (NASDAQ:GLPG).
December 2016 Stock Considerations
The final ‘stock considerations’ post of 2016 is finally at hand.
AbbVie Inc (ABBV), Alkermes PLC (ALKS): Will Woodford Investment's Long Positions Rule the Market Again in Q4?
Woodford Investment Management is a London-based hedge fund founded in 2016 by Neil Woodford. At the end of the June quarter, Woodford managed a public equity portfolio valued at $2.13 billion.
AbbVie Inc (ABBV) Wins Patent Battle Against Coherus Biosciences Inc (CHRS)
The US Patent and Trademark Office (USPTO) Patent Trial and Appeal Board (PTAB) has decided not to embark on the review of the 166 formulation patent of AbbVie Inc (NYSE:ABBV) as requested by Coherus ...
AbbVie Inc (ABBV) Stock: Skyrocketing On IP Chatter | Coherus Biosciences Inc (CHRS) Stock Tanking
AbbVie Inc (NYSE:ABBV) and Coherus Biosciences Inc (NASDAQ:CHRS) were both off to a relatively normal start in the market today. While both were trading in the green, they weren't gaining by much.
- First
- << Previous
- 381 - 390
- Next >>
Billionaire Hedge Funds
